News

The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, months before they were abruptly fired by U.S. Health Secretary Robert F ...
Shares of Moderna MRNA rose nearly 6% yesterday after the U.S. Centers for Disease Control and Prevention (“CDC”) adopted new recommendations for the use of RSV vaccines in the upcoming respiratory ...
The expanded recommendation is good news for Moderna, Pfizer, and GSK, which all sell RSV vaccines for older adults. Moderna shares were up 5.9% on Wednesday, while Pfizer was up 1%. GSK’s American ...
The U.S. Centers for Disease Control and Prevention has accepted recommendations made by an advisory panel in April on the use of respiratory syncytial virus vaccines in adults aged between 50 and 59 ...
The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50, down from 60, following the advice of a recently fired panel of government vaccine advisers. The ...
Fact checked by Nick Blackmer The Centers for Disease Control and Prevention (CDC) has expanded the RSV vaccine ...
The first vaccines to guard against the respiratory illness RSV will soon be available for some older adults, ages 60 and over, after the CDC formally backed recommendations for the shots.. The ...
MADISON, Wis. -- The Centers for Disease Control and Prevention announced Wednesday it has updated its recommendations for the use of RSV vaccines in people ages 60 and older. The CDC now ...
CDC issues new guidelines for RSV vaccines, citing side-effect concerns. Nicoletta Lanese. Tue, August 6, 2024 at 7:36 PM UTC. 4 min read. When you buy through links on our articles, Future and ...
The endorsement from CDC Director Dr. Rochelle Walensky follows recommendations from the agency’s independent vaccine advisory committee and approvals from the US Food and Drug Administration ...
In today's health headlines, the CDC changes its RSV vaccine recommendations, fruits and vegetables may have the power to reduce the risk for some serious diseases and emergency medicine doctors ...
The U.S. Centers for Disease Control and Prevention has accepted recommendations made by an advisory panel in April on the use of respiratory syncytial virus vaccines in adults aged between 50 and ...